首页> 美国卫生研究院文献>Pediatric Reports >Comparison of the methods of fibrinolysis by tube thoracostomy and thoracoscopic decortication in children with stage II and III empyema: a prospective randomized study
【2h】

Comparison of the methods of fibrinolysis by tube thoracostomy and thoracoscopic decortication in children with stage II and III empyema: a prospective randomized study

机译:II期和III期脓胸患儿通过胸腔镜开胸术和胸腔镜脱纤术进行纤维蛋白溶解方法的比较:一项前瞻性随机研究

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Today, in spite of the developments in imaging methods and antibiotherapy, childhood pleural empyema is a prominent cause of morbidity and mortality. In recent years, it has been shown that there has been an increase in the frequency of pleural empyema in children, and antibiotic resistance in microorganisms causing pleural empyema has made treatment difficult. Despite the many studies investigating thoracoscopic debridement and fibrinolytic treatment separately in the management of this disease, there is are not enough studies comparing these two treatments. The aim of this study was to prospectively compare the efficacy of two different treatment methods in stage II and III empyema cases and to present a perspective for treatment options.We excluded from the study cases with: i) thoracoscopic intervention and fibrinolytic agent were contraindicated; ii) immunosuppression or additional infection focus; iii) concomitant diseases, those with bronchopleural fistula diagnosed radiologically, and Stage I cases. This gave a total of 54 cases: 23 (42.6%) in stage II, and 31 (57.4%) cases in stage III. These patients were randomized into two groups of 27 cases each for debridement or fibrinolytic agent application by video-assisted thoracoscopic decortication (VATS). The continuity of symptoms after the operation, duration of thoracic tube in situ, and the length of hospital stay in the VATS group were of significantly shorter duration than in the streptokinase applications (P=0.0001). In 19 of 27 cases (70.37%) in which fibrinolytic treatment was applied and in 21 cases of 27 (77.77%) in which VATS was applied, the lung was fully expanded and the procedure was considered successful. There was no significant difference with respect to success rates between the two groups (P=0.533). The complication rate in our cases was 12.96% and no mortality was observed. Similar success rates in thoracoscopic drainage and enzymatic debridement, and the low cost of enzymatic drainage both served to highlight intrapleural streptokinase treatment as a reliable method in reducing the need for surgery in complicated empyema.
机译:如今,尽管在影像学方法和抗生物疗法方面有所发展,但儿童胸膜积脓仍是发病率和死亡率的重要原因。近年来,已经显示出儿童胸膜积脓的频率增加,并且引起胸膜积脓的微生物的抗生素抗性使得治疗困难。尽管有许多研究单独探讨胸腔镜清创术和纤溶治疗在该疾病的治疗中的作用,但尚无足够的研究比较这两种治疗方法。本研究的目的是前瞻性比较两种不同的治疗方法在II期和III期脓胸病例中的疗效,并为治疗方案提供一个前景。我们排除了以下研究病例:i)胸腔镜干预和纤溶剂是禁忌的; ii)免疫抑制或其他感染重点; iii)伴随疾病,经放射学诊断为支气管胸膜瘘的疾病,以及I期病例。总共54例:第二阶段23例(42.6%),第三阶段31例(57.4%)。将这些患者随机分为两组,每组27例,分别通过电视胸腔镜脱皮术(VATS)进行清创或纤溶剂应用。 VATS组患者术后症状的连续性,胸管原位持续时间和住院时间明显短于链激酶的使用时间(P = 0.0001)。在进行纤维蛋白溶解治疗的27例中有19例(70.37%),在进行了VATS的27例中有21例(77.77%)中,肺部完全扩张,手术被认为是成功的。两组之间的成功率没有显着差异(P = 0.533)。在我们的病例中,并发症发生率为12.96%,未观察到死亡率。胸腔镜引流术和酶促清创术的成功率相近,酶促引流术的成本低,都凸显了胸膜内链激酶治疗是减少复杂脓胸手术的可靠方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号